Thus, we concluded that glucosamine inhibits the proliferation of NSCLC cells by reducing the expression of IGF-1R, and the extent of the glucosamine-induced reduction in the pAkt level is associated with the anticancer effect of glucosamine. Here, IGF1R is linked to non-small cell lung carcinoma.